MARK CORRIGAN Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for MARK CORRIGAN.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of MARK CORRIGAN. MARK CORRIGAN is Executive VP, R&D in Sunovion Pharmaceuticals Inc. ($SEPR) and Executive, VP R&D in Sunovion Pharmaceuticals Inc. ($SEPR) and Director in NOVELION THERAPEUTICS INC. ($QLTI) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Director in CoLucid Pharmaceuticals, Inc. ($CLCD) and Director in Wave Life Sciences Ltd. ($WVE) and Director in Nabriva Therapeutics plc ($NBRV) and Director in Nabriva Therapeutics Plc ($NBRV).

Latest Insider Trading Transactions of MARK CORRIGAN

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CLCD, CRXX, NBRV, NBRV, NVLN, SEPR, WVE

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Aug 20 2020	WVE	Wave Life Sciences ...	CORRIGAN MARK	Director	Option Exercise	A	9.13	10,500	95,865	10,500
Sep 06 2019	WVE	Wave Life Sciences ...	CORRIGAN MARK	Director	Option Exercise	A	21.03	21,000	441,630	21,000
Aug 01 2019	NBRV	Nabriva Therapeuti ...	CORRIGAN MARK	Director	Option Exercise	A	0.00	35,000	0	35,000
Aug 13 2018	NVLN	NOVELION THERAPEUT ...	CORRIGAN MARK	Director	Option Exercise	A	3.33	50,000	166,500	50,000
May 04 2018	NBRV	Nabriva Therapeuti ...	CORRIGAN MARK	Director	Option Exercise	A	0.00	29,000	0	29,000
Sep 19 2017	NBRV	Nabriva Therapeuti ...	CORRIGAN MARK	Director	Option Exercise	A	0.00	10,100	0	10,100
Jun 27 2017	NBRV	Nabriva Therapeuti ...	CORRIGAN MARK	Director	Option Exercise	J	0.00	10,100	0	10,100
Jun 27 2017	NBRV	Nabriva Therapeuti ...	CORRIGAN MARK	Director	Option Exercise	J	0.00	20,200	0	20,200
Mar 31 2017	QLTI	NOVELION THERAPEUT ...	CORRIGAN MARK	Director	Option Exercise	A	10.64	9,600	102,144	9,600
Mar 01 2017	CLCD	CoLucid Pharmaceut ...	CORRIGAN MARK	Director	Option Exercise	D	6.24	8,897	55,517	0
Mar 01 2017	CLCD	CoLucid Pharmaceut ...	CORRIGAN MARK	Director	Option Exercise	D	3.79	8,114	30,752	0
May 12 2016	CLCD	CoLucid Pharmaceut ...	CORRIGAN MARK	Director	Option Exercise	A	6.24	8,897	55,517	8,897
Oct 29 2015	CLCD	CoLucid Pharmaceut ...	CORRIGAN MARK	Director	Option Exercise	A	3.79	8,114	30,752	8,114
Jun 08 2015	CRXX	EPIRUS Biopharmace ...	CORRIGAN MARK	Director	Option Exercise	A	6.39	9,000	57,510	9,000
Oct 22 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Option Exercise	D	14.40	57,500	828,000	0
Oct 22 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Option Exercise	D	21.26	42,165	896,428	0
Oct 22 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Option Exercise	D	16.78	70,000	1,174,600	0
Oct 22 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	D	23.00	70,668	1,625,364	0	70.7 K to 0 (-100.00 %)
Oct 19 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	U	23.00	20,749	477,227	70,668	91.4 K to 70.7 K (-22.70 %)
May 14 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Option Exercise	A	14.40	57,500	828,000	57,500
May 14 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Grant	A	14.40	35,000	504,000	91,417	56.4 K to 91.4 K (+62.04 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.86	400	5,544	56,417	56.8 K to 56.4 K (-0.70 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.83	300	4,149	56,817	57.1 K to 56.8 K (-0.53 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.82	83	1,147	57,117	57.2 K to 57.1 K (-0.15 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.81	300	4,143	57,200	57.5 K to 57.2 K (-0.52 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.80	400	5,520	57,500	57.9 K to 57.5 K (-0.69 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.76	400	5,504	57,900	58.3 K to 57.9 K (-0.69 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.75	300	4,125	58,300	58.6 K to 58.3 K (-0.51 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.74	300	4,122	58,600	58.9 K to 58.6 K (-0.51 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.73	500	6,865	58,900	59.4 K to 58.9 K (-0.84 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.72	300	4,116	59,400	59.7 K to 59.4 K (-0.50 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.71	600	8,226	59,700	60.3 K to 59.7 K (-1.00 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.69	400	5,476	60,300	60.7 K to 60.3 K (-0.66 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.62	309	4,209	60,700	61 K to 60.7 K (-0.51 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.61	91	1,239	61,009	61.1 K to 61 K (-0.15 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.57	200	2,714	61,100	61.3 K to 61.1 K (-0.33 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.52	100	1,352	61,300	61.4 K to 61.3 K (-0.16 %)
May 05 2009	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	13.51	500	6,755	61,400	61.9 K to 61.4 K (-0.81 %)
Jun 05 2008	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	20.94	3,100	64,914	61,900	65 K to 61.9 K (-4.77 %)
Jun 05 2008	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	20.93	1,832	38,344	65,000	66.8 K to 65 K (-2.74 %)
Jun 05 2008	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Sell	S	20.92	568	11,883	66,832	67.4 K to 66.8 K (-0.84 %)
May 22 2008	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Option Exercise	A	21.26	42,165	896,428	42,165
May 22 2008	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Grant	A	21.26	35,000	744,100	67,400	32.4 K to 67.4 K (+108.02 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Option Exercise	M	27.70	40,000	1,108,000	0
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Option Exercise	M	16.78	140,000	2,349,200	0
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.96	6,600	309,936	152,218	158.8 K to 152.2 K (-4.16 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.94	1,500	70,410	158,818	160.3 K to 158.8 K (-0.94 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.93	2,200	103,246	160,318	162.5 K to 160.3 K (-1.35 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.92	4,300	201,756	162,518	166.8 K to 162.5 K (-2.58 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.91	3,397	159,353	166,818	170.2 K to 166.8 K (-2.00 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.90	5,058	237,220	170,215	175.3 K to 170.2 K (-2.89 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.89	1,425	66,818	175,273	176.7 K to 175.3 K (-0.81 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.88	1,600	75,008	176,698	178.3 K to 176.7 K (-0.90 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.87	2,182	102,270	178,298	180.5 K to 178.3 K (-1.21 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Buy	S	46.86	3,477	162,932	108,480	105 K to 108.5 K (+3.31 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Buy	S	46.85	1,800	84,330	183,957	182.2 K to 184 K (+0.99 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.84	1,900	88,996	185,757	187.7 K to 185.8 K (-1.01 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Buy	S	46.83	4,103	192,143	187,657	183.6 K to 187.7 K (+2.24 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.82	3,500	163,870	191,760	195.3 K to 191.8 K (-1.79 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.81	2,540	118,897	195,260	197.8 K to 195.3 K (-1.28 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.80	2,560	119,808	197,800	200.4 K to 197.8 K (-1.28 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.79	1,209	56,569	200,360	201.6 K to 200.4 K (-0.60 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.78	1,740	81,397	201,569	203.3 K to 201.6 K (-0.86 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.77	2,318	108,413	203,309	205.6 K to 203.3 K (-1.13 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.76	473	22,117	205,627	206.1 K to 205.6 K (-0.23 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Buy	S	46.75	2,100	98,175	206,100	204 K to 206.1 K (+1.03 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.73	300	14,019	208,200	208.5 K to 208.2 K (-0.14 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.72	500	23,360	208,500	209 K to 208.5 K (-0.24 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.71	800	37,368	209,000	209.8 K to 209 K (-0.38 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.70	600	28,020	209,800	210.4 K to 209.8 K (-0.29 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.69	1,600	74,704	210,400	212 K to 210.4 K (-0.75 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.68	100	4,668	212,000	212.1 K to 212 K (-0.05 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.67	300	14,001	212,100	212.4 K to 212.1 K (-0.14 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Buy	M	27.70	40,000	1,108,000	212,400	172.4 K to 212.4 K (+23.20 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Buy	M	16.78	140,000	2,349,200	172,400	32.4 K to 172.4 K (+432.10 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.42	380	18,020	32,400	32.8 K to 32.4 K (-1.16 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.41	200	9,482	32,780	33 K to 32.8 K (-0.61 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.40	3,000	142,200	32,980	36 K to 33 K (-8.34 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.39	900	42,651	35,980	36.9 K to 36 K (-2.44 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.38	200	9,476	36,880	37.1 K to 36.9 K (-0.54 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.37	600	28,422	37,080	37.7 K to 37.1 K (-1.59 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.36	30	1,421	37,680	37.7 K to 37.7 K (-0.08 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.35	300	14,205	37,710	38 K to 37.7 K (-0.79 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.34	500	23,670	38,010	38.5 K to 38 K (-1.30 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.33	800	37,864	38,510	39.3 K to 38.5 K (-2.04 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.32	280	13,250	39,310	39.6 K to 39.3 K (-0.71 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.31	400	18,924	39,590	40 K to 39.6 K (-1.00 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.30	320	15,136	39,990	40.3 K to 40 K (-0.79 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.29	600	28,374	40,310	40.9 K to 40.3 K (-1.47 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.28	1,000	47,280	40,910	41.9 K to 40.9 K (-2.39 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.27	2,500	118,175	41,910	44.4 K to 41.9 K (-5.63 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.26	5,005	236,536	44,410	49.4 K to 44.4 K (-10.13 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.25	7,385	348,941	49,415	56.8 K to 49.4 K (-13.00 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.24	2,220	104,873	56,800	59 K to 56.8 K (-3.76 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.23	2,854	134,794	59,020	61.9 K to 59 K (-4.61 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.22	2,203	104,026	61,874	64.1 K to 61.9 K (-3.44 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.21	3,661	172,836	64,077	67.7 K to 64.1 K (-5.40 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.20	3,136	148,019	67,738	70.9 K to 67.7 K (-4.42 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.19	3,726	175,830	70,874	74.6 K to 70.9 K (-4.99 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.18	2,200	103,796	74,600	76.8 K to 74.6 K (-2.86 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.17	2,200	103,774	76,800	79 K to 76.8 K (-2.78 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.16	3,468	163,551	79,000	82.5 K to 79 K (-4.21 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.15	4,400	207,460	82,468	86.9 K to 82.5 K (-5.07 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.14	2,532	119,358	86,868	89.4 K to 86.9 K (-2.83 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.13	2,200	103,686	89,400	91.6 K to 89.4 K (-2.40 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.12	2,100	98,952	91,600	93.7 K to 91.6 K (-2.24 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.11	4,691	220,993	93,700	98.4 K to 93.7 K (-4.77 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.10	4,671	220,004	98,391	103.1 K to 98.4 K (-4.53 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.09	6,248	294,218	103,062	109.3 K to 103.1 K (-5.72 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.08	7,321	344,673	109,310	116.6 K to 109.3 K (-6.28 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.07	7,081	333,303	116,631	123.7 K to 116.6 K (-5.72 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Buy	S	47.06	2,288	107,673	123,712	121.4 K to 123.7 K (+1.88 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.05	1,100	51,755	126,000	127.1 K to 126 K (-0.87 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.04	1,500	70,560	127,100	128.6 K to 127.1 K (-1.17 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.03	1,650	77,600	128,600	130.3 K to 128.6 K (-1.27 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.02	5,400	253,908	130,250	135.7 K to 130.3 K (-3.98 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.01	3,300	155,133	135,650	139 K to 135.7 K (-2.37 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	47.00	3,884	182,548	138,950	142.8 K to 139 K (-2.72 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.99	2,234	104,976	142,834	145.1 K to 142.8 K (-1.54 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.98	2,000	93,960	145,068	147.1 K to 145.1 K (-1.36 %)
Jun 15 2007	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive, VP R&D	Sell	S	46.97	5,150	241,896	147,068	152.2 K to 147.1 K (-3.38 %)
Feb 11 2004	SEPR	Sunovion Pharmaceu ...	CORRIGAN MARK	Executive VP, R&D	Grant	A	27.70	100,000	2,770,000	0	-100,000 to 0 (-100.00 %)

Page: 1